Multiple Sclerosis and Pregnancy

Building Clinical Confidence
General Neurology Activity Home
- Cases
What Would You Do Activity Home
- Question 1
- Video 1
- Question 2
- Video 2
- Question 3
- Video 3
- Question 4
- Video 4
- Question 5
- Video 5
- Question 6
- Video 6
- Question 7
- Video 7
- Question 8
- Video 8
- Question 9
- Video 9
- Question 10
- Video 10
- Question 11
- Video 11
- Question 12
- Video 12
- End
Cognition
Digital
A Clinician’s Guide to the 2021 MAGNIMS–CMSC–NAIMS Consensus Recommendations on the use of MRI in Patients with MS
Expert Insights on COVID-19 Prophylaxis Monograph
Essentials in Multiple Sclerosis Care – A Comprehensive Curriculum for MS Nurses
Exploring Aging and Multiple Sclerosis Management
Multiple Sclerosis and Pregnancy
Under Construction

Postsurvey

Multiple Sclerosis and Pregnancy: Expert Guidance on Care Across the Continuum

Please choose the best answer for the questions below, then click the button at the bottom to proceed.

Items marked with * require a response.
How confident are you in collaborating with the care team to communicate effectively and educate women of childbearing potential with multiple sclerosis (MS) about family planning?*
- Not at all confident
- Slightly confident
- Moderately confident
- Very confident
- Extremely confident
How well do you understand the key clinical, safety, and patient-specific factors that should be discussed with a woman of childbearing potential when considering disease-modifying therapy (DMT) options for MS?*
- Not at all
- Slightly
- Moderately
- Very well
- Extremely well
How confident are you in evaluating individual patient characteristics and DMT profiles, including pharmacokinetics, safety profiles, risk of fetal harm, and potential for rebound disease activity, to guide decisions on timing DMT dosing or bridging in relation to conception?*
- Not at all confident
- Slightly confident
- Moderately confident
- Very confident
- Extremely confident
How confident are you in interpreting clinical data on the safety of oral, injectable, and infusible DMTs for use during pregnancy?*
- Not at all confident
- Slightly confident
- Moderately confident
- Very confident
- Extremely confident
How well do you understand the impact of pregnancy and the postpartum state on MS disease activity, including the risk of relapse?*
- Not at all
- Slightly
- Moderately
- Very well
- Extremely well
How familiar are you with recommendations for comprehensive postpartum care in women with MS, including evidence-based guidance on DMT use in relation to breastfeeding?*
- Not at all familiar
- Slightly familiar
- Moderately familiar
- Very familiar
- Extremely familiar

PostsurveyMultiple Sclerosis and Pregnancy: Expert Guidance on Care Across the Continuum

Postsurvey

Multiple Sclerosis and Pregnancy: Expert Guidance on Care Across the Continuum